Netta M. Makinen
Helsinki, 00290, Finland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Molecular subclass of uterine fibroids predicts tumor shrinkage in response to ulipristal acetate.
Journal: Human molecular genetics
Published: March 24, 2022
Comparison of 2SC, AKR1B10, and FH Antibodies as Potential Biomarkers for FH-deficient Uterine Leiomyomas.
Journal: The American journal of surgical pathology
Published: October 22, 2021
Deficient H2A.Z deposition is associated with genesis of uterine leiomyoma.
Journal: Nature
Published: June 26, 2020
Parity associates with chromosomal damage in uterine leiomyomas.
Journal: Nature communications
Published: January 27, 2020
Exome and immune cell score analyses reveal great variation within synchronous primary colorectal cancers.
Journal: British journal of cancer
Published: October 25, 2018
Loss of ATRX/DAXX expression and alternative lengthening of telomeres in uterine leiomyomas.
Journal: Cancer
Published: June 18, 2018
Exome-wide somatic mutation characterization of small bowel adenocarcinoma.
Journal: PLoS genetics
Published: September 20, 2017
Global metabolomic profiling of uterine leiomyomas.
Journal: British journal of cancer
Published: June 07, 2017
Multiple clinical characteristics separate MED12-mutation-positive and -negative uterine leiomyomas.
Multiple clinical characteristics separate MED12-mutation-positive and -negative uterine leiomyomas.
Journal: Scientific reports
Published: February 03, 2017
Somatic MED12 Nonsense Mutation Escapes mRNA Decay and Reveals a Motif Required for Nuclear Entry.
Journal: Human mutation
Published: June 28, 2016
MED12 mutations and FH inactivation are mutually exclusive in uterine leiomyomas.
Journal: British journal of cancer
Published: February 09, 2016
Last Updated: 09/26/2026